← All organizations
Highest phase reached
Phase 4
First clinical trial
May 1, 2004First marketed drug
Jan 17, 2008First NDA
Jan 17, 2008Last known activity
May 1, 2010
Acquired by Bristol-Myers Squibb on Jan 1, 2010
Timeline
1980s
- Jan 1, 1981
ZymoGenetics— Founded
2000s
- Jan 17, 2008
thrombin (human coagulation factor iia) (Recombinant)— NDA Organization
2010s
- Jan 1, 2010
Bristol-Myers Squibb— Acquired By
Drugs by trial phase (11 distinct, 11 trials)
Phase 4 (1 own, 0 via acquisition)
Phase 3 (4 own, 0 via acquisition)
Phase 2 (5 own, 0 via acquisition)
Phase 1 (1 own, 0 via acquisition)
Indications
Marketed drugs (1)
Recent trials (19)
- NCT01001754Study directorPhase 2May 1, 2010
- NCT01001754Lead sponsorPhase 2May 1, 2010
- NCT00859547Lead sponsorPhase 4Mar 1, 2009
- NCT00813904Lead sponsorPhase 4Jan 1, 2009
- NCT00573157CollaboratorPhase 2/Phase 3Dec 1, 2007
- NCT00565539Study directorPhase 1Dec 1, 2007
- NCT00565539Lead sponsorPhase 1Dec 1, 2007
- NCT00491608Study directorPhase 3Jun 1, 2007
- NCT00491608Lead sponsorPhase 3Jun 1, 2007
- NCT00389285Lead sponsorPhase 1/Phase 2Oct 1, 2006
- NCT00389285Study directorPhase 1/Phase 2Oct 1, 2006
- NCT00371215Lead sponsorPhase 2Aug 1, 2006
- NCT00371215Study directorPhase 2Aug 1, 2006
- NCT00347971Lead sponsorPhase 1Jun 1, 2006
- NCT00347971Study directorPhase 1Jun 1, 2006
Details
- Founded
- Seattle, WA, US Jan 1, 1981
- First NDA
- Jan 17, 2008
- Last known activity
- May 1, 2010